Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Describe the T cell receptor
|
A transmembrane receptor that is obligatorily associated with the CD3 complex. CD3 functions as the signal transducing unit
|
|
What are the two different types of MHC molecules, and what are they associated with?
|
MHC I, associated with CD8+ & MHC II, associated with CD4+
|
|
What was the MHC first associated with
|
Rapid rejection of tissue transplants
|
|
What is another name for the MHC
|
Human leukocyte antigens (HLAs)
|
|
Which genes are the most polymorphic genes in the genome of mammals
|
MHC genes
|
|
What are the three MHC I genes
|
HLA-A,B,C
|
|
What are the three MHC II genes
|
HLA-DR,DP,DQ
|
|
What is the structure of MHC I
|
a MHC-encoded heavy chain (alpha chain) and a light non-MHC encoded subunit (B2-microglobulin). The alpha chain has a1 and a2 polymorphic domains, and a3 segement that binds CD8
|
|
What is the structure of MHC II
|
two chains of equivalent mass: alpha chain and Beta chain. a1 and B1 form the peptide binding cleft, and nonpolymorphic B2 binds CD4
|
|
Which pathway uses MHC I
|
Endogenous, for antigens found in the cytosol. Includes viruses and other intracellular pathogens. Found in all nucleated cells
|
|
How are cytosolic proteins targeted for degradation
|
Covalent addition of ubiquitin, which leads it to a proteasome
|
|
Which pathway uses MHC II
|
The exogenous pathway, for antigens outside the cell. Used only by professionals, such as dendritic cells, macrophages, and B cells
|
|
What stabilizes the MHC II molecules during lysosomal fusion
|
CLIP, which will be replaced by the peptide
|
|
What do MHC molecules bind?
How is peptide selection determined by the MHC? What do these pockets specify? |
- Both foreign and self peptides
- by the size and shape of “pockets” in the floor of the MHC molecule - subsets of peptides, which contain specific anchor residues that fit into the pockets |
|
What good are polymorphisms?
How? |
- They increase both the variety of peptides that are recognized and the variety of TCRs that can bind
- polymorphisms cause a change in size and shape of the pockets. |
|
What stabilizes the TCR/MHC-peptide interaction
|
CD8 or CD4
|
|
Why do extensive polymorphisms exist
|
To counter evasive strategies of pathogens
|
|
Definition of Major Histocompatibility Complex (MHC)?
General Nomenclature of MHC for humans? |
- an extended genetic locus encoding specialized proteins that were originally
characterized as the primary (“major”) locus influencing skin graft acceptance or rejection (“histocompatibility”) - Human Leukocyte Antigens (HLA) |
|
What is the function of the MHC?
|
- Cell-associated MHC + antigen stimulates the T cell receptor (TCR)
|
|
Are NK cell Killer-Inhibitory Receptors (KIRs) antigen-specific?
|
- No they are NOT antigen-specific (peptide is irrelevant)
|
|
What did Snell’s experiments demonstrate?
|
- That a graft with a differing MHC is the primary locus responsible for graft rejection
|
|
What role does MHC have in immunity?
|
- w/o MHC, there is no Ab response, and thus no adaptive immunity
|
|
What chromosome are the MHC genes located?
What are the Class I MHC? What are the Class II MHC? |
- Chromosome 6
- HLA-A, -B, -C - HLA-DR, -DP, -DQ |
|
Which cells express Class I MHC?
|
- all nucleated cells (every cell of every organ/tissue; NOT red blood cells)
|
|
Which cells express Class II MHC?
|
- restricted to “professional” antigen- presenting cells (APCs) = Dendritic cells (most important APC), B cells, Macrophages
|
|
What is the associated HLA allele of ankylosing spondylitis?
|
B27
|
|
What is the associated HLA allele of Reactive arthritis (Yersinia, Salmonella, Gonococcus)?
|
B27
|
|
What is the associated HLA allele of Reiter’s syndrome?
|
B27
|
|
Ankylosing spondylitis, reactive arthritis, and Reiter’s syndrome all show B27 as the associated HLA allele. What does this show?
|
- shows that MHC gene polymorphism is highly medically relevant
|
|
What are the two sources of peptides?
|
- Cytosolic (“endogenous”) proteins: e.g., host cell structural proteins, viral pathogen proteins
- Extracellular (“exogenous”) proteins: e.g., host serum proteins, bacterial pathogen proteins |
|
What is the MHC association of Cytosolic (“endogenous”) peptides?
What is the MHC association of extracellular (“exogenous”) peptides? |
- associate with MHC class I
- associate with MHC class II |
|
What is the endogenous pathway of MHC class I antigen processing and presentation?
How does the cytosolic ptn transport from the cytosol to ER? |
- Production of ptns in cytosol -> proteolytic degradation of ptns -> transport of peptides from cytosol to ER -> assembly of peptide-class I MHCcomplexes in ER -> surface expression of peptide-class I complexes
- Two TAP Gene Products Form a Transporter Complex That Moves Peptides From the Cytosol to the ER |
|
What is the exogenous pathway of MHC class II antigen processing and presentation?
|
- Uptake of extracellular ptns into vesicular compartments of APC -> processing of internalized ptns in endosomal/lysosomal vesicles -> biosynthesis and transport of class II MHC molecules to endosomes -> association of processed peptides with class II MHC molecules in vesicles -> expression of peptide-MHC complexes on cell surface
|
|
What is the function of the invariant chain (Ii)?
How does this affect the processing and presentation of extracellular antigen from intracellular antigen? |
- blocks the peptide binding groove
of MHC II until fusion with low-pH lysosomes/endosomes - peptide does not get sent to the ER for further processing; instead it goes straight to the surface to be presented. For intracellular peptides, peptides get processed in ER and Golgi, and THEN gets presented on the surface. |
|
Intracellular pathogens: viruses, etc are associated with which type of MHC class?
How does evolution explain this? |
- MHC class I
- All cells are vulnerable to such infections, and all cells must thus have a way of presenting such pathogen peptides to T cells, for recognition and elimination |
|
Extracellular pathogens: bacteria, fungi, etc are associated with which type of MHC class?
How does evolution explain this? |
- MHC class II
- These pathogens can be readily accessed by phagocytosis and other engulfment mechanisms. The evolution of specialized antigen sampling cells is a very efficient way to monitor the entire extracellular space of an organism. |
|
What determines the peptide binding specificity of the MHC?
What affects the size and shape of these pockets? |
- Binding specificity is determined by the size and shape of “pockets” in the peptide-biding groove of the MHC molecule
- Individual MHC genes and alleles have peptide-binding pockets in different sizes, shapes, and locations. Thus, distinct alleles bind different subsets of peptides |
|
Where are the MHC polymorphisms located?
What do polymorphisms influence (2)? |
- Polymorphisms occur in regions of the MHC
that contact the peptide and the TCR - 1) MHC binding to peptides and 2) MHC recognition by the TCR |
|
How does the peptide influence the
binding of the TCR? |
- Peptide residues which are not buried in the MHC groove
serve as binding sites for the TCR |
|
What does CD8 bind to on MHC I?
What does CD4 bind to on MHC II? |
- Alpha 3 domain
- Beta 2 domain |
|
What is a rule about MHC termed MHC restriction?
|
- A given TCR will only recognize a specific MHC molecule in complex with a unique (or a few similar) peptide(s)
|
|
Why is the knowledge of MHC restriction of T cell responses to antigen important?
|
- b/c it is the basis of functional T cell immunity and transplant rejection
|
|
Inability of an individual’s MHC to efficiently present peptides from the specific pathogen can cause what?
Then how is this problem solved? |
- individual may be highly susceptible to infection by a specific pathogen
- within the community or “herd” as a whole, individuals will have many different MHC alleles, of which many will bind the pathogen peptides conferring resistance to pathogen infection = MHC becomes highly polymorphic |
|
What is needed for long-term allograft survival after tissue transplant?
|
- good cross-matching btwn donor and recipient and immuno-suppressive drug treatment
|
|
What is the most useful test in definitive diagnosis of many autoimmune diseases?
|
- HLA typing
|